ClinicalTrials.gg
CompletedNCT07768774Updated Aug 17, 2026

Pediatric Parental Feeding Video Education Program

An interventional study of Pediatric Parental Feeding Video Education Program in Feeding Behavior, sponsored by Johnson & Wales University. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-17.

Sponsored by Johnson & Wales University · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 1 year 6 months after the study started (first participant enrolled Nov 2022, registered May 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
27
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this preliminary clinical trial is to evaluate the preliminary efficacy, acceptability, and feasibility of a distance-based parental feeding education program among low-income and food-insecure parents/caregivers of children (ages 2 to 8).

Participants will

  • Watch short parental feeding and food access videos over the course of eight weeks.
  • Receive handouts and other printed materials regarding evidence-based parental feeding practices and food access resources.
  • Participate in three motivational interview calls.
  • Provide feedback on the acceptability of the videos.
02

Conditions studied

  • Feeding Behavior

Browse trials for

03

In context

Feeding Behavior

985 studies on the registry are indexed under Feeding Behavior; 178 are open to participants now.

This study's enrollment of 27 is below the median of 77 across 700 interventional studies indexed under Feeding Behavior.

Browse Feeding Behavior studies →

Lead sponsor

This is the only study on the registry with Johnson & Wales University as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Able to read and speak English or Spanish
  • Parent or caregiver of a child ages 2-8
  • Screened positive for food insecurity during a primary care pediatric clinic visit

Exclusion criteria

Exclusion Criteria:

  • Unable to read and speak English or Spanish
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
27 participants (actual)

Study arms

  • Experimental
    Pilot Feasibility Study Participants

    Only one arm of this study exists- receipt of the pilot intervention. Intervention includes educational videos, printed educational materials, and motivational interview phone calls.

    Behavioral: Pediatric Parental Feeding Video Education Program

Interventions

  • BehavioralPediatric Parental Feeding Video Education Program

    Distance-based nutrition and food access education program including educational videos, printed materials, and motivational interviewing sessions.

06

What researchers measure

Primary outcomes

  1. Food Security Status

    Response to USDA short screener for food insecurity

    Time frame: 8 weeks

07

Study locations

1 site
  • Hasbro Children's Hospital
    Providence, Rhode Island 02906, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2022 to primary completion in Aug 2024, 21 months.

Of 503 non-industry interventional studies with no phase under Feeding Behavior, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's 21 months is above that.

Counting every sponsor, half of 515 studies reached it within 14 months; a quarter within 5 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
May 26, 2024
First posted
Aug 17, 2026
StartActual
Nov 1, 2022
Primary completionActual
Aug 1, 2024
CompletionActual
Dec 1, 2024
Last update
Aug 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07768774
Lead sponsor
Johnson & Wales University
Responsible party
Sponsor
First posted
Aug 17, 2026
Start date
Nov 1, 2022
Primary completion
Aug 1, 2024
Completion
Dec 1, 2024
Last update
Aug 17, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion